Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COvid MEdicaTion (COMET) study: protocol for a cohort study.
Sablerolles RSG, Hogenhuis FEF, Lafeber M, van de Loo BPA, Borgsteede SD, Boersma E, Versmissen J, van der Kuy HM; COMET Research team. Sablerolles RSG, et al. Eur J Hosp Pharm. 2020 Jul;27(4):191-193. doi: 10.1136/ejhpharm-2020-002329. Eur J Hosp Pharm. 2020. PMID: 32587077 Free PMC article.
Treatment response heterogeneity in asthma: the role of genetic variation.
Vijverberg SJH, Farzan N, Slob EMA, Neerincx AH, Maitland-van der Zee AH. Vijverberg SJH, et al. Expert Rev Respir Med. 2018 Jan;12(1):55-65. doi: 10.1080/17476348.2018.1403318. Epub 2017 Nov 21. Expert Rev Respir Med. 2018. PMID: 29115880 Free article. Review.
What do we need to transfer pharmacogenetics findings into the clinic?
Slob EMA, Vijverberg SJH, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH. Slob EMA, et al. Pharmacogenomics. 2018 May;19(7):589-592. doi: 10.2217/pgs-2018-0026. Epub 2018 Apr 27. Pharmacogenomics. 2018. PMID: 29701121 No abstract available.
Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study.
Slob EMA, Brew BK, Vijverberg SJH, Kats CJAR, Longo C, Pijnenburg MW, van Beijsterveldt TCEM, Dolan CV, Bartels M, Magnusson P, Lichtenstein P, Gong T, Koppelman GH, Almqvist C, Boomsma DI, Maitland-van der Zee AH. Slob EMA, et al. Eur Respir J. 2020 Apr 23;55(4):1902021. doi: 10.1183/13993003.02021-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 32139457 Free article.
Early-life antibiotic use and risk of attention-deficit hyperactivity disorder and autism spectrum disorder: results of a discordant twin study.
Slob EMA, Brew BK, Vijverberg SJH, Dijs T, van Beijsterveldt CEM, Koppelman GH, Bartels M, Dolan CV, Larsson H, Lundström S, Lichtenstein P, Gong T, Maitland-van der Zee AH, Kraneveld AD, Almqvist C, Boomsma DI. Slob EMA, et al. Int J Epidemiol. 2021 May 17;50(2):475-484. doi: 10.1093/ije/dyaa168. Int J Epidemiol. 2021. PMID: 33179025 Free PMC article.
Genome-wide association studies of exacerbations in children using long-acting beta2-agonists.
Slob EMA, Richards LB, Vijverberg SJH, Longo C, Koppelman GH, Pijnenburg MWH, Bel EHD, Neerincx AH, Herrera Luis E, Perez-Garcia J, Tim Chew F, Yie Sio Y, Andiappan AK, Turner SW, Mukhopadhyay S, Palmer CNA, Hawcutt D, Jorgensen AL, Burchard EG, Hernandez-Pacheco N, Pino-Yanes M, Maitland-van der Zee AH. Slob EMA, et al. Pediatr Allergy Immunol. 2021 Aug;32(6):1197-1207. doi: 10.1111/pai.13494. Epub 2021 Mar 29. Pediatr Allergy Immunol. 2021. PMID: 33706416 Free PMC article.
Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study.
Alizadeh Bahmani AH, Slob EMA, Bloemsma LD, Brandstetter S, Corcuera-Elosegui P, Gorenjak M, Harner S, Hashimoto S, Hedman AM, Kabesch M, Koppelman GH, Korta-Murua J, Kraneveld AD, Neerincx AH, Pijnenburg MW, Pino-Yanes M, Potočnik U, Sardón-Prado O, Vijverberg SJH, Wolff C, Abdel-Aziz MI, Maitland-van der Zee AH; SysPharmPediA consortium. Alizadeh Bahmani AH, et al. Eur J Pharm Sci. 2023 Feb 1;181:106360. doi: 10.1016/j.ejps.2022.106360. Epub 2022 Dec 13. Eur J Pharm Sci. 2023. PMID: 36526249 Free article.
57 results